Form 8-K - Current report:
SEC Accession No. 0000950170-25-107357
Filing Date
2025-08-12
Accepted
2025-08-12 16:20:00
Documents
12
Period of Report
2025-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prok-20250812.htm   iXBRL 8-K 45138
2 EX-99.1 prok-ex99_1.htm EX-99.1 388850
3 GRAPHIC img22993735_0.jpg GRAPHIC 34636
  Complete submission text file 0000950170-25-107357.txt   612891

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT prok-20250812.xsd EX-101.SCH 25828
14 EXTRACTED XBRL INSTANCE DOCUMENT prok-20250812_htm.xml XML 4897
Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Filer) CIK: 0001850270 (see all company filings)

EIN.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40560 | Film No.: 251207020
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)